Key result
Prophylactic anticoagulation fails to improve clinical outcomes in HF patients with sinus rhythm.
Why the study?
Although thromboembolic risk is increased in heart failure without atrial fibrillation, it remains unclear whether patients with heart failure and sinus rhythm benefit from prophylactic anticoagulation.
Does prophylactic anticoagulant therapy improve clinical outcomes in patients with heart failure and sinus rhythm?
Does prophylactic anticoagulant therapy improve clinical outcomes in patients with heart failure and sinus rhythm?
Prophylactic anticoagulation is not beneficial for patients with heart failure in sinus rhythm due to a lack of primary outcome improvement and increased bleeding risk.
Answers are grounded in this paper and cite their sources.
No benefit seen with prophylactic anticoagulation in HF sinus rhythm; leaves open questions on subgroups or newer agents.
The risk of thromboembolic events is significantly increased among patients with heart failure, even in those without atrial fibrillation. However, it is still unclear whether patients with heart failure and sinus rhythm can benefit from prophylactic anticoagulant therapy.This was a retrospective review of the pathophysiological mechanisms, epidemiological studies, and clinical trials on anticoagulation in patients with heart failure and sinus rhythm.Some subgroup analyses of clinical trials found that prophylactic anticoagulant therapy could reduce the incidence of stroke in patients with heart failure and sinus rhythm, and the risk of bleeding was significantly increased. Regarding the incidence of primary endpoint outcomes, all results from clinical trials were negative.Prophylactic anticoagulation did not improve the clinical outcome in patients with heart failure and sinus rhythm.
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) conducted a review in Heart failure and sinus rhythm. Prophylactic anticoagulation was evaluated on Primary endpoint outcomes. Prophylactic anticoagulation did not improve clinical outcomes in patients with heart failure and sinus rhythm, with all clinical trials showing negative results for primary endpoints.
Synapse has enriched 10 related papers. Consider them for comparative context: